Tilray, a licensed cannabis producer in Canada and owned by Seattle-based Privateer Holdings, has become the first Canadian company licensed by Canada’s Marihuana for Medical Purposes Regulations to legally export medical cannabis cultivated and processed in Canada.
On June 10, 2016, Tilray announced that it had sent a shipment of medical cannabis products to eligible patients in Croatia, marking the European Union’s first legal importation of commercial medical use products with THC from North America.
Tilray has partnered with the Croatian Institute of Immunology to distribute the products in Croatia. Patients will have two liquid capsule formulations to choose from, with the first formulation containing 5.0 mg of THC and 5.0 mg of cannabidiol, and the second formulation containing 2.5 mg of THC and 2.0 mg of CBD per capsule.
According to Professor Ognjen Brborović PhD MD, Chairman of Croatia’s Committee for Medical Cannabis, “It took eight months for the Committee for Medical Cannabis to deliver necessary documents needed to change Croatian legislation to get cannabis to Croatian patients. It took another eight months of diligent work with Tilray to secure all certificates and licenses needed to import and distribute cannabinoid preparations into the European Union from Canada and for actual production of the first batch of cannabis extract oil.”
“I am glad that Croatia is the first EU country that will be able to assure patients first-class cannabis extract oil is available in pharmacies. I hope that patients in other EU countries will soon have the same opportunity,” Brborović said.